Marc Better, VP, Product Sciences at Kite Pharma, Inc. (KITE), sold 9,000 shares at $46.50 ($426K) on 2016-02-01, disclosed to the SEC on 2016-02-03.
Open-market sale of $426k KITE by VP, Product Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.50 | 2,499 | $116K | 27.3% |
| 2 | $47.38 | 4,938 | $234K | 54.9% |
| 3 | $48.47 | 1,410 | $68K | 16.0% |
| 4 | $49.20 | 153 | $8K | 1.8% |
| Total | $47.34 avg | 9,000 | $426K | 100% |
| Filing → |
| KITE | SELL | 2015-11-04 | $640K | — | Filing → |
| KITE | SELL | 2015-10-02 | $493K | — | Filing → |
| KITE | SELL | 2015-09-03 | $466K | — | Filing → |